149 related articles for article (PubMed ID: 15857631)
1. Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist.
Dautzenberg FM; Higelin J; Pflieger P; Neidhart W; Guba W
Neuropharmacology; 2005 Jun; 48(7):1043-55. PubMed ID: 15857631
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins.
Dautzenberg FM
Biochem Pharmacol; 2005 May; 69(10):1493-9. PubMed ID: 15857613
[TBL] [Abstract][Full Text] [Related]
3. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
[TBL] [Abstract][Full Text] [Related]
4. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
Odagaki Y; Nishi N; Nakagawa S; Koyama T
J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
[TBL] [Abstract][Full Text] [Related]
10. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo.
Mullins D; Kirby D; Hwa J; Guzzi M; Rivier J; Parker E
Mol Pharmacol; 2001 Sep; 60(3):534-40. PubMed ID: 11502885
[TBL] [Abstract][Full Text] [Related]
11. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
12. Identification of high-potency neuropeptide Y analogues through systematic lactamization.
Kirby DA; Britton KT; Aubert ML; Rivier JE
J Med Chem; 1997 Jan; 40(2):210-5. PubMed ID: 9003519
[TBL] [Abstract][Full Text] [Related]
13. Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia.
Xapelli S; Bernardino L; Ferreira R; Grade S; Silva AP; Salgado JR; Cavadas C; Grouzmann E; Poulsen FR; Jakobsen B; Oliveira CR; Zimmer J; Malva JO
Eur J Neurosci; 2008 Apr; 27(8):2089-102. PubMed ID: 18412629
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
Körner M; Reubi JC
J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
[TBL] [Abstract][Full Text] [Related]
15. The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity.
Walker MW; Wolinsky TD; Jubian V; Chandrasena G; Zhong H; Huang X; Miller S; Hegde LG; Marsteller DA; Marzabadi MR; Papp M; Overstreet DH; Gerald CP; Craig DA
J Pharmacol Exp Ther; 2009 Mar; 328(3):900-11. PubMed ID: 19098165
[TBL] [Abstract][Full Text] [Related]
16. Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells.
Pop N; Igel P; Brennauer A; Cabrele C; Bernhardt GN; Seifert R; Buschauer A
J Recept Signal Transduct Res; 2011 Aug; 31(4):271-85. PubMed ID: 21745157
[TBL] [Abstract][Full Text] [Related]
17. Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice.
Christensen DZ; Olesen MV; Kristiansen H; Mikkelsen JD; Woldbye DP
J Neurosci Res; 2006 Nov; 84(6):1282-91. PubMed ID: 16941487
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
19. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function.
Cox HM
Auton Neurosci; 2007 Apr; 133(1):76-85. PubMed ID: 17140858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]